{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:50:03Z","timestamp":1768618203411,"version":"3.49.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/NEU\/04539\/2019"],"award-info":[{"award-number":["UID\/NEU\/04539\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04539\/2020"],"award-info":[{"award-number":["UIDB\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04539\/2020"],"award-info":[{"award-number":["UIDP\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11033-021-06266-4","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T19:03:07Z","timestamp":1616007787000},"page":"2791-2802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oxidative stress in bladder cancer: an ally or an enemy?"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-8939","authenticated-orcid":false,"given":"Fernando","family":"Mendes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-2989","authenticated-orcid":false,"given":"Eurico","family":"Pereira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1457-8992","authenticated-orcid":false,"given":"Diana","family":"Martins","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8612-0147","authenticated-orcid":false,"given":"Edgar","family":"Tavares-Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7994-4650","authenticated-orcid":false,"given":"Ana Salom\u00e9","family":"Pires","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4185-7871","authenticated-orcid":false,"given":"Ana Margarida","family":"Abrantes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-0081","authenticated-orcid":false,"given":"Arnaldo","family":"Figueiredo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-1650","authenticated-orcid":false,"given":"Maria Filomena","family":"Botelho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"6266_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"6266_CR2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41598-018-19199-z","volume":"8","author":"MCS Wong","year":"2018","unstructured":"Wong MCS, Fung FDH, Leung C, Cheung WWL, Goggins WB, Ng CF (2018) The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep 8:1129. https:\/\/doi.org\/10.1038\/s41598-018-19199-z","journal-title":"Sci Rep"},{"key":"6266_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medsci8010015","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of bladder cancer. Med Sci 8:15. https:\/\/doi.org\/10.3390\/medsci8010015","journal-title":"Med Sci"},{"key":"6266_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10654-016-0138-6","volume":"31","author":"AH Al-Zalabani","year":"2016","unstructured":"Al-Zalabani AH, Stewart KFJ, Wesselius A, Schols AMWJ, Zeegers MP (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 31:811\u2013851. https:\/\/doi.org\/10.1007\/s10654-016-0138-6","journal-title":"Eur J Epidemiol"},{"key":"6266_CR5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM (2020) The global burden of urinary bladder cancer: an update. World J Urol 38:1895\u20131904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4","journal-title":"World J Urol"},{"key":"6266_CR6","doi-asserted-by":"crossref","unstructured":"Shin JH, Lim JS, Jeon BH (2018) Pathophysiology of bladder cancer. In Bladder Cancer. Elsevier, Amsterdam, pp 33\u201341 ISBN 9780128099407","DOI":"10.1016\/B978-0-12-809939-1.00003-5"},{"key":"6266_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.humpath.2010.07.007","volume":"42","author":"L Cheng","year":"2011","unstructured":"Cheng L, Zhang S, MacLennan GT, Williamson SR, Lopez-Beltran A, Montironi R (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 42:455\u2013481. https:\/\/doi.org\/10.1016\/j.humpath.2010.07.007","journal-title":"Hum Pathol"},{"key":"6266_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2016.03.053","volume":"70","author":"S Naito","year":"2016","unstructured":"Naito S, Algaba F, Babjuk M, Bryan RT, Sun Y-H, Valiquette L, de la Rosette J (2016) The Clinical Research Office of the Endourological Society (CROES) multicentre randomised trial of narrow band imaging-assisted transurethral resection of bladder tumour (TURBT) versus conventional white light imaging-assisted TURBT in primary non\u2013muscle-. Eur Urol 70:506\u2013515. https:\/\/doi.org\/10.1016\/j.eururo.2016.03.053","journal-title":"Eur Urol"},{"key":"6266_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"key":"6266_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Hern\u00e1ndez V, Kaasinen E, Palou J, Roupr\u00eat M et al (2017) EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.041","journal-title":"Eur Urol"},{"key":"6266_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0090-4295(80)90322-2","volume":"16","author":"R Bruce Bracken","year":"1980","unstructured":"Bruce Bracken R, Swanson DA, Johnson DE, De Furia D, Von Eschenbach AC, Crooke S (1980) Role of intravesical mitomycin c in management of superficial bladder tumors. Urology 16:11\u201315. https:\/\/doi.org\/10.1016\/0090-4295(80)90322-2","journal-title":"Urology"},{"key":"6266_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors. J Urol 116:180\u2013182. https:\/\/doi.org\/10.1016\/S0022-5347(17)58737-6","journal-title":"J Urol"},{"key":"6266_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/annonc\/mdz127","volume":"30","author":"Y Fradet","year":"2019","unstructured":"Fradet Y, Bellmunt J, Vaughn DJ, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A et al (2019) Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up. Ann Oncol 30:970\u2013976. https:\/\/doi.org\/10.1093\/annonc\/mdz127","journal-title":"Ann Oncol"},{"key":"6266_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0140-6736(17)33297-X","volume":"391","author":"T Powles","year":"2018","unstructured":"Powles T, Dur\u00e1n I, van der Heijden MS, Loriot Y, Vogelzang NJ, De Giorgi U, Oudard S, Retz MM, Castellano D, Bamias A et al (2018) Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial. Lancet 391:748\u2013757. https:\/\/doi.org\/10.1016\/S0140-6736(17)33297-X","journal-title":"Lancet"},{"key":"6266_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1470-2045(17)30065-7","volume":"18","author":"P Sharma","year":"2017","unstructured":"Sharma P, Retz M, Siefker-Radtke A, Baron A, Necchi A, Bedke J, Plimack ER, Vaena D, Grimm M-O, Bracarda S et al (2017) Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol 18:312\u2013322. https:\/\/doi.org\/10.1016\/S1470-2045(17)30065-7","journal-title":"Lancet Oncol"},{"key":"6266_CR16","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","volume":"23","author":"H von der Maase","year":"2005","unstructured":"von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23:4602\u20134608. https:\/\/doi.org\/10.1200\/JCO.2005.07.757","journal-title":"J Clin Oncol"},{"key":"6266_CR17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s12094-020-02330-w","volume":"22","author":"D Liu","year":"2020","unstructured":"Liu D, Qiu X, Xiong X, Chen X, Pan F (2020) Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics. Clin Transl Oncol 22:1687\u20131697. https:\/\/doi.org\/10.1007\/s12094-020-02330-w","journal-title":"Clin Transl Oncol"},{"key":"6266_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.urolonc.2008.12.010","volume":"28","author":"N Badjatia","year":"2010","unstructured":"Badjatia N, Satyam A, Singh P, Seth A, Sharma A (2010) Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol Semin Orig Investig 28:360\u2013367. https:\/\/doi.org\/10.1016\/j.urolonc.2008.12.010","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"6266_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12253-019-00620-5","volume":"26","author":"E Sawicka","year":"2020","unstructured":"Sawicka E, Kratz EM, Szyma\u0144ska B, Guzik A, Weso\u0142owski A, Kowal P, Pawlik-Sobecka L, Piwowar A (2020) Preliminary study on selected markers of oxidative stress, inflammation and angiogenesis in patients with bladder cancer. Pathol Oncol Res 26:821\u2013831. https:\/\/doi.org\/10.1007\/s12253-019-00620-5","journal-title":"Pathol Oncol Res"},{"key":"6266_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00232-017-9971-0","volume":"250","author":"\u0130 Gecit","year":"2017","unstructured":"Gecit \u0130, Ery\u0131lmaz R, Kavak S, Meral \u0130, Demir H, Pirin\u00e7\u00e7i N, G\u00fcne\u015f M, Taken K (2017) The prolidase activity, oxidative stress, and nitric oxide levels of bladder tissues with or without tumor in patients with bladder cancer. J Membr Biol 250:455\u2013459. https:\/\/doi.org\/10.1007\/s00232-017-9971-0","journal-title":"J Membr Biol"},{"key":"6266_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","volume":"12","author":"V Sosa","year":"2013","unstructured":"Sosa V, Molin\u00e9 T, Somoza R, Paciucci R, Kondoh H, Lleonart ME (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12:376\u2013390. https:\/\/doi.org\/10.1016\/j.arr.2012.10.004","journal-title":"Ageing Res Rev"},{"key":"6266_CR22","doi-asserted-by":"publisher","first-page":"42740","DOI":"10.18632\/oncotarget.8600","volume":"7","author":"Y Liu","year":"2016","unstructured":"Liu Y, Li Q, Zhou L, Xie N, Nice EC, Zhang H, Huang C, Lei Y (2016) Cancer drug resistance: redox resetting renders a way. Oncotarget 7:42740\u201342761. https:\/\/doi.org\/10.18632\/oncotarget.8600","journal-title":"Oncotarget"},{"key":"6266_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21147\/j.issn.1000-9604.2016.04.01","volume":"28","author":"D Ivanova","year":"2016","unstructured":"Ivanova D, Zhelev Z, Aoki I, Bakalova R, Higashi T (2016) Overproduction of reactive oxygen species\u2014obligatory or not for induction of apoptosis by anticancer drugs. Chin J Cancer Res 28:383\u2013396. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2016.04.01","journal-title":"Chin J Cancer Res"},{"key":"6266_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1245049","volume":"2016","author":"S Di Meo","year":"2016","unstructured":"Di Meo S, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev 2016:1\u201344. https:\/\/doi.org\/10.1155\/2016\/1245049","journal-title":"Oxid Med Cell Longev"},{"key":"6266_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1515\/hsz-2017-0152","volume":"398","author":"S Tharmalingam","year":"2017","unstructured":"Tharmalingam S, Alhasawi A, Appanna VP, Lemire J, Appanna VD (2017) Reactive nitrogen species (RNS)-resistant microbes: adaptation and medical implications. Biol Chem 398:1193\u20131208. https:\/\/doi.org\/10.1515\/hsz-2017-0152","journal-title":"Biol Chem"},{"key":"6266_CR26","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1158\/1078-0432.CCR-12-1554","volume":"19","author":"EA Grimm","year":"2013","unstructured":"Grimm EA, Sikora AG, Ekmekcioglu S (2013) Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target. Clin Cancer Res 19:5557\u20135563. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1554","journal-title":"Clin Cancer Res"},{"key":"6266_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2018.08.012","volume":"49","author":"N Lau","year":"2019","unstructured":"Lau N, Pluth MD (2019) Reactive sulfur species (RSS): persulfides, polysulfides, potential, and problems. Curr Opin Chem Biol 49:1\u20138. https:\/\/doi.org\/10.1016\/j.cbpa.2018.08.012","journal-title":"Curr Opin Chem Biol"},{"key":"6266_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.plaphy.2012.03.016","volume":"59","author":"MCH Gruhlke","year":"2012","unstructured":"Gruhlke MCH, Slusarenko AJ (2012) The biology of reactive sulfur species (RSS). Plant Physiol Biochem 59:98\u2013107. https:\/\/doi.org\/10.1016\/j.plaphy.2012.03.016","journal-title":"Plant Physiol Biochem"},{"key":"6266_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.redox.2017.11.009","volume":"15","author":"KR Olson","year":"2018","unstructured":"Olson KR, Gao Y, Arif F, Arora K, Patel S, DeLeon ER, Sutton TR, Feelisch M, Cortese-Krott MM, Straub KD (2018) Metabolism of hydrogen sulfide (H2S) and production of reactive sulfur species (RSS) by superoxide dismutase. Redox Biol 15:74\u201385. https:\/\/doi.org\/10.1016\/j.redox.2017.11.009","journal-title":"Redox Biol"},{"key":"6266_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/ars.2017.7083","volume":"27","author":"MM Cortese-Krott","year":"2017","unstructured":"Cortese-Krott MM, Koning A, Kuhnle GGC, Nagy P, Bianco CL, Pasch A, Wink DA, Fukuto JM, Jackson AA, van Goor H et al (2017) The reactive species interactome: evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine. Antioxid Redox Signal 27:684\u2013712. https:\/\/doi.org\/10.1089\/ars.2017.7083","journal-title":"Antioxid Redox Signal"},{"key":"6266_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6235641","volume":"2016","author":"B Marengo","year":"2016","unstructured":"Marengo B, Nitti M, Furfaro AL, Colla R, de Ciucis C, Marinari UM, Pronzato MA, Traverso N, Domenicotti C (2016) Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy. Oxid Med Cell Longev 2016:1\u201316. https:\/\/doi.org\/10.1155\/2016\/6235641","journal-title":"Oxid Med Cell Longev"},{"key":"6266_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12011-013-9682-z","volume":"153","author":"S Mao","year":"2013","unstructured":"Mao S, Huang S (2013) Zinc and copper levels in bladder cancer: a systematic review and meta-analysis. Biol Trace Elem Res 153:5\u201310. https:\/\/doi.org\/10.1007\/s12011-013-9682-z","journal-title":"Biol Trace Elem Res"},{"key":"6266_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2019.01.031","volume":"134","author":"P Whongsiri","year":"2019","unstructured":"Whongsiri P, Pimratana C, Wijitsettakul U, Sanpavat A, Jindatip D, Hoffmann MJ, Goering W, Schulz WA, Boonla C (2019) Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation. Free Radic Biol Med 134:419\u2013428. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.01.031","journal-title":"Free Radic Biol Med"},{"key":"6266_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2020.1718636","author":"M G\u00fcnes","year":"2020","unstructured":"G\u00fcnes M, Eryilmaz R, Aslan R, Taken K, Demir H, Demir C (2020) Oxidant-antioxidant levels in patients with bladder tumours. Aging Male. https:\/\/doi.org\/10.1080\/13685538.2020.1718636","journal-title":"Aging Male"},{"key":"6266_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","volume":"160","author":"M Valko","year":"2006","unstructured":"Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1\u201340. https:\/\/doi.org\/10.1016\/j.cbi.2005.12.009","journal-title":"Chem Biol Interact"},{"key":"6266_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2730896","volume":"2019","author":"MO Islam","year":"2019","unstructured":"Islam MO, Bacchetti T, Ferretti G (2019) Alterations of antioxidant enzymes and biomarkers of nitro-oxidative stress in tissues of bladder cancer. Oxid Med Cell Longev 2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/2730896","journal-title":"Oxid Med Cell Longev"},{"key":"6266_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5152\/tud.2017.89411","volume":"43","author":"MM Utangac","year":"2017","unstructured":"Utangac MM, Yeni E, Savas M, Altunkol A, Ciftci H, Gumus K, Demir M (2017) Paraoxonase and arylesterase activity in bladder cancer. T\u00fcrk \u00dcroloji Dergisi\/Turk J Urol 43:147\u2013151. https:\/\/doi.org\/10.5152\/tud.2017.89411","journal-title":"T\u00fcrk \u00dcroloji Dergisi\/Turk J Urol"},{"key":"6266_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00432-011-1136-4","volume":"138","author":"I Gecit","year":"2012","unstructured":"Gecit I, Aslan M, Gunes M, Pirincci N, Esen R, Demir H, Ceylan K (2012) Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer. J Cancer Res Clin Oncol 138:739\u2013743. https:\/\/doi.org\/10.1007\/s00432-011-1136-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"6266_CR39","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.7314\/APJCP.2013.14.6.3773","volume":"14","author":"W Wongpaiboonwattana","year":"2013","unstructured":"Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C (2013) Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pac J Cancer Prev 14:3773\u20133778. https:\/\/doi.org\/10.7314\/APJCP.2013.14.6.3773","journal-title":"Asian Pac J Cancer Prev"},{"key":"6266_CR40","doi-asserted-by":"publisher","first-page":"e37009","DOI":"10.1371\/journal.pone.0037009","volume":"7","author":"M Patchsung","year":"2012","unstructured":"Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P (2012) Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS ONE 7:e37009. https:\/\/doi.org\/10.1371\/journal.pone.0037009","journal-title":"PLoS ONE"},{"key":"6266_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.21873\/cgp.20072","volume":"15","author":"P Whongsiri","year":"2018","unstructured":"Whongsiri P, Pimratana C, Wijitsettakul U, Jindatip D, Sanpavat A, Schulz WA, Hoffmann MLJ, Goering W, Boonla C (2018) LINE-1 ORF1 protein is up-regulated by reactive oxygen species and associated with bladder urothelial carcinoma progression. Cancer Genomics Proteomics 15:143\u2013151. https:\/\/doi.org\/10.21873\/cgp.20072","journal-title":"Cancer Genomics Proteomics"},{"key":"6266_CR42","doi-asserted-by":"crossref","unstructured":"Kavitha S (2015) Cancer biology. In Viva voce in biochemistry, vol 168. Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, pp 185\u2013185 ISBN 9781620816493.","DOI":"10.5005\/jp\/books\/12453_30"},{"key":"6266_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7:97\u2013110. https:\/\/doi.org\/10.1016\/j.drup.2004.01.004","journal-title":"Drug Resist Updat"},{"key":"6266_CR44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2017.12.005","volume":"115","author":"E Ciamporcero","year":"2018","unstructured":"Ciamporcero E, Daga M, Pizzimenti S, Roetto A, Dianzani C, Compagnone A, Palmieri A, Ullio C, Cangemi L, Pili R et al (2018) Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer. Free Radic Biol Med 115:447\u2013457. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.12.005","journal-title":"Free Radic Biol Med"},{"key":"6266_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579\u2013591. https:\/\/doi.org\/10.1038\/nrd2803","journal-title":"Nat Rev Drug Discov"},{"key":"6266_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","volume":"16","author":"K Taguchi","year":"2011","unstructured":"Taguchi K, Motohashi H, Yamamoto M (2011) Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123\u2013140. https:\/\/doi.org\/10.1111\/j.1365-2443.2010.01473.x","journal-title":"Genes Cells"},{"key":"6266_CR47","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3892\/ijo.2017.4089","volume":"51","author":"Y Sun","year":"2017","unstructured":"Sun Y, Guan Z, Zhao W, Jiang Y, Li Q, Cheng Y, Xu Y (2017) Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-\u03baB signal-dependent and signal-independent manner. Int J Oncol 51:1219\u20131226. https:\/\/doi.org\/10.3892\/ijo.2017.4089","journal-title":"Int J Oncol"},{"key":"6266_CR48","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","volume":"29","author":"A Umemura","year":"2016","unstructured":"Umemura A, He F, Taniguchi K, Nakagawa H, Yamachika S, Font-Burgada J, Zhong Z, Subramaniam S, Raghunandan S, Duran A et al (2016) p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29:935\u2013948. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.006","journal-title":"Cancer Cell"},{"key":"6266_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M (2018) NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18:309\u2013324. https:\/\/doi.org\/10.1038\/nri.2017.142","journal-title":"Nat Rev Immunol"},{"key":"6266_CR50","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/onc.2015.219","volume":"35","author":"E Ciamporcero","year":"2016","unstructured":"Ciamporcero E, Shen H, Ramakrishnan S, Yu KS, Chintala S, Shen L, Adelaiye R, Miles KM, Ullio C, Pizzimenti S et al (2016) YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene 35:1541\u20131553. https:\/\/doi.org\/10.1038\/onc.2015.219","journal-title":"Oncogene"},{"key":"6266_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3892\/ijo.2018.4376","volume":"53","author":"X Yang","year":"2018","unstructured":"Yang X, Yin H, Zhang Y, Li X, Tong H, Zeng Y, Wang Q, He W (2018) Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1\u03b1 activation. Int J Oncol 53:215\u2013224. https:\/\/doi.org\/10.3892\/ijo.2018.4376","journal-title":"Int J Oncol"},{"key":"6266_CR52","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2217\/epi.12.39","volume":"4","author":"S Haenisch","year":"2012","unstructured":"Haenisch S, Cascorbi I (2012) miRNAs as mediators of drug resistance. Epigenomics 4:369\u2013381. https:\/\/doi.org\/10.2217\/epi.12.39","journal-title":"Epigenomics"},{"key":"6266_CR53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1476-4598-13-234","volume":"13","author":"H Deng","year":"2014","unstructured":"Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y, Xiao J, Qian L, Zhao W, Liu Q et al (2014) miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway. Mol Cancer 13:234. https:\/\/doi.org\/10.1186\/1476-4598-13-234","journal-title":"Mol Cancer"},{"key":"6266_CR54","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/ijms21030937","volume":"21","author":"I Giacomini","year":"2020","unstructured":"Giacomini I, Ragazzi E, Pasut G, Montopoli M (2020) The pentose phosphate pathway and its involvement in cisplatin resistance. Int J Mol Sci 21:937. https:\/\/doi.org\/10.3390\/ijms21030937","journal-title":"Int J Mol Sci"},{"key":"6266_CR55","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cellbi.2006.02.005","volume":"30","author":"A Gonenc","year":"2006","unstructured":"Gonenc A, Erten D, Aslan S, Akinci M, Simsek B, Torun M (2006) Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 30:376\u2013380. https:\/\/doi.org\/10.1016\/j.cellbi.2006.02.005","journal-title":"Cell Biol Int"},{"key":"6266_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ijc.1565","volume":"97","author":"M Marikovsky","year":"2002","unstructured":"Marikovsky M, Nevo N, Vadai E, Harris-Cerruti C (2002) Cu\/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer 97:34\u201341. https:\/\/doi.org\/10.1002\/ijc.1565","journal-title":"Int J Cancer"},{"key":"6266_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/molecules24030453","volume":"24","author":"W Blaszczak","year":"2019","unstructured":"Blaszczak W, Barczak W, Masternak J, Kopczy\u0144ski P, Zhitkovich A, Rubi\u015b B (2019) Vitamin C as a modulator of the response to cancer therapy. Molecules 24:453. https:\/\/doi.org\/10.3390\/molecules24030453","journal-title":"Molecules"},{"key":"6266_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3747\/co.25.3790","volume":"25","author":"E Klimant","year":"2018","unstructured":"Klimant E, Wright H, Rubin D, Seely D, Markman M (2018) Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach. Curr Oncol 25:139. https:\/\/doi.org\/10.3747\/co.25.3790","journal-title":"Curr Oncol"},{"key":"6266_CR59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1464-410X.2003.04729.x","volume":"93","author":"O Yal\u00e7in","year":"2004","unstructured":"Yal\u00e7in O, Karata\u015f F, Erula\u015f FA, \u00d6zdemir E (2004) The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int 93:863\u2013866. https:\/\/doi.org\/10.1111\/j.1464-410X.2003.04729.x","journal-title":"BJU Int"},{"key":"6266_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2015.12.003","volume":"162","author":"HY Peh","year":"2016","unstructured":"Peh HY, Tan WSD, Liao W, Wong WSF (2016) Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther 162:152\u2013169. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.12.003","journal-title":"Pharmacol Ther"},{"key":"6266_CR61","doi-asserted-by":"publisher","DOI":"10.2174\/1566524018666171205113329","author":"A Jain","year":"2018","unstructured":"Jain A, Tiwari A, Verma A, Jain SK (2018) Vitamins for cancer prevention and treatment: an insight. Curr Mol Med. https:\/\/doi.org\/10.2174\/1566524018666171205113329","journal-title":"Curr Mol Med"},{"key":"6266_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00126839-200506030-00004","volume":"6","author":"SMKR Zaidi","year":"2005","unstructured":"Zaidi SMKR, Al-Qirim TM, Banu N (2005) Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver. Drugs R D 6:157\u2013165. https:\/\/doi.org\/10.2165\/00126839-200506030-00004","journal-title":"Drugs R D"},{"key":"6266_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5363064","volume":"2018","author":"GM Calaf","year":"2018","unstructured":"Calaf GM, Aguayo F, Sergi CM, Juarranz A, Roy D (2018) Antioxidants and cancer: theories, techniques, and trials in preventing cancer. Oxid Med Cell Longev 2018:1\u20132. https:\/\/doi.org\/10.1155\/2018\/5363064","journal-title":"Oxid Med Cell Longev"},{"key":"6266_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrurol.2017.179","volume":"15","author":"KM Felsenstein","year":"2018","unstructured":"Felsenstein KM, Theodorescu D (2018) Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy. Nat Rev Urol 15:92\u2013111. https:\/\/doi.org\/10.1038\/nrurol.2017.179","journal-title":"Nat Rev Urol"},{"key":"6266_CR65","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931\u2013947. https:\/\/doi.org\/10.1038\/nrd4002","journal-title":"Nat Rev Drug Discov"},{"key":"6266_CR66","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1101\/gad.1756509.GENES","volume":"23","author":"RG Jones","year":"2009","unstructured":"Jones RG, Thompson CB (2009) Tumor suppressors and cell metabolism. Genes Dev 23:537\u2013548. https:\/\/doi.org\/10.1101\/gad.1756509.GENES","journal-title":"Genes Dev"},{"key":"6266_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2013.06.042","volume":"437","author":"JM Liu","year":"2013","unstructured":"Liu JM, Pan F, Li L, Liu QR, Chen Y, Xiong XX, Cheng K, Yu SB, Shi Z, Yu AC-H et al (2013) Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun 437:87\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2013.06.042","journal-title":"Biochem Biophys Res Commun"},{"key":"6266_CR68","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbrc.2017.10.061","volume":"494","author":"D Liu","year":"2017","unstructured":"Liu D, Qiu XY, Wu X, Hu DX, Li CY, Yu SB, Pan F, Chen XQ (2017) Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization. Biochem Biophys Res Commun 494:165\u2013172. https:\/\/doi.org\/10.1016\/j.bbrc.2017.10.061","journal-title":"Biochem Biophys Res Commun"},{"key":"6266_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409\u2013435. https:\/\/doi.org\/10.1146\/annurev.med.53.082901.104018","journal-title":"Annu Rev Med"},{"key":"6266_CR70","doi-asserted-by":"publisher","first-page":"35783","DOI":"10.1038\/srep35783","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Cao R, Wang Y, Qian G, Dan HC, Jiang W, Ju L, Wu M, Xiao Y, Wang X (2016) Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPAR\u03b3 signalling pathway. Sci Rep 6:35783. https:\/\/doi.org\/10.1038\/srep35783","journal-title":"Sci Rep"},{"key":"6266_CR71","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.canlet.2017.11.015","volume":"414","author":"R Cao","year":"2018","unstructured":"Cao R, Wang G, Qian K, Chen L, Ju L, Qian G, Wu C-L, Dan HC, Jiang W, Wu M et al (2018) TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPAR\u03b3-SIRT1 feedback loop in human bladder cancer cells. Cancer Lett 414:278\u2013293. https:\/\/doi.org\/10.1016\/j.canlet.2017.11.015","journal-title":"Cancer Lett"},{"key":"6266_CR72","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00432-010-0910-z","volume":"137","author":"S Choudhary","year":"2011","unstructured":"Choudhary S, Rathore K, Wang H-CR (2011) Differential induction of reactive oxygen species through Erk1\/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells. J Cancer Res Clin Oncol 137:471\u2013480. https:\/\/doi.org\/10.1007\/s00432-010-0910-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"6266_CR73","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00432-009-0608-2","volume":"135","author":"S Choudhary","year":"2009","unstructured":"Choudhary S, Wang H-CR (2009) Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction. J Cancer Res Clin Oncol 135:1601\u20131613. https:\/\/doi.org\/10.1007\/s00432-009-0608-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"6266_CR74","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/cbr.2012.1468","volume":"28","author":"H Wang","year":"2013","unstructured":"Wang H, Jiang D, Liu J, Ye S, Xiao S, Wang W, Sun Z, Xie Y, Wang J (2013) Compound K induces apoptosis of bladder cancer T24 cells via reactive oxygen species-mediated p38 MAPK pathway. Cancer Biother Radiopharm 28:607\u2013614. https:\/\/doi.org\/10.1089\/cbr.2012.1468","journal-title":"Cancer Biother Radiopharm"},{"key":"6266_CR75","doi-asserted-by":"publisher","first-page":"e0161886","DOI":"10.1371\/journal.pone.0161886","volume":"11","author":"F Duan","year":"2016","unstructured":"Duan F, Yu Y, Guan R, Xu Z, Liang H, Hong L (2016) Vitamin K2 induces mitochondria-related apoptosis in human bladder cancer cells via ROS and JNK\/p38 MAPK signal pathways. PLoS ONE 11:e0161886. https:\/\/doi.org\/10.1371\/journal.pone.0161886","journal-title":"PLoS ONE"},{"key":"6266_CR76","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/1535-7163.MCT-10-0577","volume":"10","author":"J Zeng","year":"2011","unstructured":"Zeng J, Sun Y, Wu K, Li L, Zhang G, Yang Z, Wang Z, Zhang D, Xue Y, Chen Y et al (2011) Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria. Mol Cancer Ther 10:104\u2013116. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0577","journal-title":"Mol Cancer Ther"},{"key":"6266_CR77","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3892\/or.2019.7013","volume":"41","author":"Z Zhuo","year":"2019","unstructured":"Zhuo Z, Song Z, Ma Z, Zhang Y, Xu G, Chen G (2019) Chlorophyllin e6-mediated photodynamic therapy inhibits proliferation and induces apoptosis in human bladder cancer cells. Oncol Rep 41:2181\u20132193. https:\/\/doi.org\/10.3892\/or.2019.7013","journal-title":"Oncol Rep"},{"key":"6266_CR78","doi-asserted-by":"publisher","first-page":"15977","DOI":"10.18632\/oncotarget.13304","volume":"8","author":"D Yan","year":"2017","unstructured":"Yan D, Sherman JH, Keidar M (2017) Cold atmospheric plasma, a novel promising anti-cancer treatment modality. Oncotarget 8:15977\u201315995. https:\/\/doi.org\/10.18632\/oncotarget.13304","journal-title":"Oncotarget"},{"key":"6266_CR79","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/cancers12020269","volume":"12","author":"ML Semmler","year":"2020","unstructured":"Semmler ML, Bekeschus S, Sch\u00e4fer M, Bernhardt T, Fischer T, Witzke K, Seebauer C, Rebl H, Grambow E, Vollmar B et al (2020) Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment. Cancers (Basel) 12:269. https:\/\/doi.org\/10.3390\/cancers12020269","journal-title":"Cancers (Basel)"},{"key":"6266_CR80","doi-asserted-by":"publisher","first-page":"040801","DOI":"10.1116\/1.4938020","volume":"10","author":"D Yan","year":"2015","unstructured":"Yan D, Talbot A, Nourmohammadi N, Sherman JH, Cheng X, Keidar M (2015) Toward understanding the selective anticancer capacity of cold atmospheric plasma\u2014a model based on aquaporins (Review). Biointerphases 10:040801. https:\/\/doi.org\/10.1116\/1.4938020","journal-title":"Biointerphases"},{"key":"6266_CR81","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/ijms21082932","volume":"21","author":"D Bran\u00fd","year":"2020","unstructured":"Bran\u00fd D, Dvorsk\u00e1 D, Hala\u0161ov\u00e1 E, \u0160kovierov\u00e1 H (2020) Cold atmospheric plasma: a powerful tool for modern medicine. Int J Mol Sci 21:2932. https:\/\/doi.org\/10.3390\/ijms21082932","journal-title":"Int J Mol Sci"},{"key":"6266_CR82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2014.11.014","volume":"79","author":"T Adachi","year":"2015","unstructured":"Adachi T, Tanaka H, Nonomura S, Hara H, Kondo S, Hori M (2015) Plasma-activated medium induces A549 cell injury via a spiral apoptotic cascade involving the mitochondrial\u2013nuclear network. Free Radic Biol Med 79:28\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.11.014","journal-title":"Free Radic Biol Med"},{"key":"6266_CR83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.freeradbiomed.2018.06.001","volume":"124","author":"L Xiang","year":"2018","unstructured":"Xiang L, Xu X, Zhang S, Cai D, Dai X (2018) Cold atmospheric plasma conveys selectivity on triple negative breast cancer cells both in vitro and in vivo. Free Radic Biol Med 124:205\u2013213. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.001","journal-title":"Free Radic Biol Med"},{"key":"6266_CR84","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/cancers9060061","volume":"9","author":"Z Chen","year":"2017","unstructured":"Chen Z, Simonyan H, Cheng X, Gjika E, Lin L, Canady J, Sherman J, Young C, Keidar M (2017) A novel micro cold atmospheric plasma device for glioblastoma both in vitro and in vivo. Cancers (Basel) 9:61. https:\/\/doi.org\/10.3390\/cancers9060061","journal-title":"Cancers (Basel)"},{"key":"6266_CR85","doi-asserted-by":"publisher","first-page":"029403","DOI":"10.1116\/1.4915264","volume":"10","author":"P Babington","year":"2015","unstructured":"Babington P, Rajjoub K, Canady J, Siu A, Keidar M, Sherman JH (2015) Use of cold atmospheric plasma in the treatment of cancer. Biointerphases 10:029403. https:\/\/doi.org\/10.1116\/1.4915264","journal-title":"Biointerphases"},{"key":"6266_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/hsz-2018-0222","volume":"400","author":"D Boehm","year":"2018","unstructured":"Boehm D, Bourke P (2018) Safety implications of plasma-induced effects in living cells\u2014a review of in vitro and in vivo findings. Biol Chem 400:3\u201317. https:\/\/doi.org\/10.1515\/hsz-2018-0222","journal-title":"Biol Chem"},{"key":"6266_CR87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/biology10010041","volume":"10","author":"E Tavares-da-Silva","year":"2021","unstructured":"Tavares-da-Silva E, Pereira E, Pires AS, Neves AR, Braz-Guilherme C, Marques IA, Abrantes AM, Gon\u00e7alves AC, Caramelo F, Silva-Teixeira R et al (2021) Cold atmospheric plasma, a novel approach against bladder cancer, with higher sensitivity for the high-grade cell line. Biology (Basel) 10:41. https:\/\/doi.org\/10.3390\/biology10010041","journal-title":"Biology (Basel)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06266-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06266-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06266-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T09:49:51Z","timestamp":1618998591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06266-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["6266"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06266-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare not to have any conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}